Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Ippoliti
Observed names:
E Ippoliti,
Elena IPPOLITI,
Ippoliti, E
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0009-6455-0531
Observed ORCID:
0009-0009-6455-0531
OpenAlex ID:
A5113153524
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
2024
·
Tiago Torres
, Andrea Chiricozzi
, et al.
·
American Journal of Clinical Dermatology
·
86
PDF
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era
2023
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Expert Opinion on Biological Therapy
·
32
PDF
Long‐term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real‐world retrospective study
2024
·
Andrea Chiricozzi
, Niccolò Gori
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
21
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment
2023
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Clinical and Experimental Dermatology
·
15
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
2023
·
A Chiricozzi
, SM Ferrucci
, et al.
·
Expert Opinion on Biological Therapy
·
13
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study
2025
·
Luca Potestio
, Cataldo Patruno
, et al.
·
International Journal of Dermatology
·
11
PDF
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series
2024
·
Niccolò Gori
, Elena Ippoliti
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
11
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study
2025
·
Francesca Barei
, Stefano Macchi
, et al.
·
Clinical and Experimental Dermatology
·
7
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled
2024
·
Giulia Coscarella
, Gennaro Marco Falco
, et al.
·
Frontiers in Medicine
·
7
PDF
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study
2025
·
Giuseppe Lauletta
, Cataldo Patruno
, et al.
·
Clinical and Experimental Dermatology
·
5
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations
2025
·
Niccolo Gori
, Alvise Sernicola
, et al.
·
Acta Dermato Venereologica
·
5
PDF
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study
2025
·
Gianluca Avallone
, Luca Valtellini
, et al.
·
Dermatitis
·
5
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study
2023
·
Flaminia Antonelli
, Elena Ippoliti
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Superior Clinical and Economic Value of IL ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
2026
·
Gennaro Marco Falco
, Elena Ippoliti
, et al.
·
International Journal of Dermatology
·
3
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors
2025
·
Niccolò Gori
, Lucia Di Nardo
, et al.
·
Journal of Dermatological Treatment
·
3
Successful Lebrikizumab Therapy in Two Patients With Atopic Dermatitis Resistant to Multiple Therapies
2025
·
Elena Ippoliti
, Niccolò Gori
, et al.
·
JEADV Clinical Practice
·
2
PDF
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab
2024
·
Niccolò Gori
, Andrea Chiricozzi
, et al.
·
Clinical and Experimental Dermatology
·
2
PDF
Successful treatment of chronic hand eczema with delgocitinib after systemic therapy failure
2026
·
Benedetta AMBROSIO
, Luisa BOETI
, et al.
·
Italian Journal of Dermatology and Venereology
·
1
Isotretinoin and Hidradenitis Suppurativa a Conflictual Binomial: Investigation on Differential Response Rate Between Inflammatory and Follicular Phenotype
2026
·
Maria Vittoria Cannizzaro
, Flaminia Antonelli
, et al.
·
JEADV Clinical Practice
·
1
Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors
2026
·
Elena Ippoliti
, Niccolò Gori
, et al.
·
Skin Health and Disease
·
1
Abrocitinib in atopic dermatitis: real-world effectiveness and safety up to 1 year
2026
·
Niccolò Gori
, Maria Vittoria Cannizzaro
, et al.
·
1
PDF
Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors
2026
·
Anna Paola Lugli
, Niccolò Gori
, et al.
·
Dermatology Reports
·
1
PDF
IL-4/IL-13 targeted biologics in atopic dermatitis: is their use safe in oncologic patients?
2026
·
Elena Ippoliti
, Luisa Boeti
, et al.
·
Expert Opinion on Biological Therapy
·
1
PDF
Long‐Term Effectiveness and Safety of Dupilumab for the Treatment of Prurigo Nodularis
2025
·
Elena Ippoliti
, Niccolò Gori
, et al.
·
International Journal of Dermatology
·
1
Long‐Term Real‐World Safety Profile of Secukinumab Assessed Through a 9‐Year Experience in Patients Affected by Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Results From a Multicentric Retrospective Study
2025
·
Elena Ippoliti
, Gennaro Marco Falco
, et al.
·
Dermatologic Therapy
·
1
PDF
Show more works
View as search
Works count:
38
Citation count:
241
H-index:
7
I10-index:
7
Year
Topic
Type